Intensive but tender care for infant ALL
- PMID: 33057700
- PMCID: PMC7568033
- DOI: 10.1182/blood.2020007863
Intensive but tender care for infant ALL
Abstract
In this issue of Blood,
Conflict of interest statement
Conflict-of-interest disclosure: The authors declare no competing financial interests.
Conflict-of-interest disclosure: The authors declare no competing financial interests.
Comment on
-
A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial.Blood. 2020 Oct 15;136(16):1813-1823. doi: 10.1182/blood.2019004741. Blood. 2020. PMID: 32845001
References
-
- Tomizawa D, Miyamura T, Imamura T, et al. . A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial. Blood. 2020;136(16):1813-1823. - PubMed
-
- Pui CH, Gaynon PS, Boyett JM, et al. . Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet. 2002;359(9321):1909-1915. - PubMed
-
- Dördelmann M, Reiter A, Borkhardt A, et al. . Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood. 1999;94(4):1209-1217. - PubMed
-
- Pieters R, Schrappe M, De Lorenzo P, et al. . A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet. 2007;370(9583):240-250. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
